Moolec Confirms US Harvest and Promising Yields for Plant-Grown Products GLASO(TM) and Piggy Sooy(TM) in October
Moolec Science SA (NASDAQ:MLEC) has announced the upcoming harvest of its genetically engineered plant-grown products GLASO™ and Piggy Sooy™ in October 2024. The GLASO™ campaign in Idaho covers 600 acres and is expected to yield 300-400 tons of high-GLA safflower seeds. Moolec has secured an offtake agreement with a major global CPG company for GLASO™, targeting the US market in 2025. Piggy Sooy™ field trials are being conducted in Ohio, Missouri, and Iowa for product development, seed increase, and regulatory data gathering. Moolec recently obtained USDA-APHIS approval for Piggy Sooy™ cultivation, marking a significant milestone in Molecular Farming. The company aims to provide sustainable solutions in agriculture and biotechnology, with Piggy Sooy™ potentially producing pork meat proteins equivalent to 10 pigs per acre while reducing environmental impact.
Moolec Science SA (NASDAQ:MLEC) ha annunciato la prossima raccolta dei suoi prodotti vegetali geneticamente ingegnerizzati GLASO™ e Piggy Sooy™ in ottobre 2024. La campagna GLASO™ in Idaho copre 600 acri e si prevede che produca 300-400 tonnellate di semi di cartamo ad alto contenuto di GLA. Moolec ha assicurato un accordo di acquisto con una grande azienda globale di beni di consumo confezionati per GLASO™, mirando al mercato statunitense nel 2025. I trial sul campo di Piggy Sooy™ sono in corso in Ohio, Missouri e Iowa per lo sviluppo del prodotto, l’aumento dei semi e la raccolta di dati normativi. Moolec ha recentemente ottenuto l'approvazione USDA-APHIS per la coltivazione di Piggy Sooy™, segnando un traguardo significativo nell'Agricoltura Molecolare. L'azienda punta a fornire soluzioni sostenibili nell'agricoltura e nella biotecnologia, con Piggy Sooy™ che potrebbe produrre proteine di carne suina equivalenti a 10 maiali per acri, riducendo al contempo l'impatto ambientale.
Moolec Science SA (NASDAQ:MLEC) ha anunciado la próxima cosecha de sus productos cultivados a partir de plantas genéticamente modificadas GLASO™ y Piggy Sooy™ en octubre de 2024. La campaña GLASO™ en Idaho abarca 600 acres y se espera que produzca entre 300 y 400 toneladas de semillas de cártamo con alto contenido de GLA. Moolec ha asegurado un acuerdo de compra con una importante empresa global de bienes de consumo empaquetados para GLASO™, con el objetivo de ingresar al mercado estadounidense en 2025. Se están llevando a cabo ensayos de campo de Piggy Sooy™ en Ohio, Missouri e Iowa para el desarrollo del producto, el aumento de semillas y la recopilación de datos regulatorios. Moolec obtuvo recientemente la aprobación de USDA-APHIS para el cultivo de Piggy Sooy™, marcando un hito significativo en la Agricultura Molecular. La empresa busca proporcionar soluciones sostenibles en agricultura y biotecnología, con Piggy Sooy™ que podría producir proteínas de carne de cerdo equivalentes a 10 cerdos por acre, reduciendo al mismo tiempo el impacto ambiental.
Moolec Science SA (NASDAQ:MLEC)는 2024년 10월에 유전자 변형 식물에서 재배된 GLASO™와 Piggy Sooy™ 제품의 수확이 예정되어 있다고 발표했습니다. 아이오와주에서 진행되는 GLASO™ 캠페인은 600에이커를 아우르며, 300~400톤의 고GLA 샤프론 씨앗을 생산할 것으로 예상됩니다. Moolec는 GLASO™에 대해 주요 글로벌 소비재 회사와 구매 계약을 체결하여 2025년 미국 시장을 겨냥하고 있습니다. Piggy Sooy™ 현장 시험은 제품 개발, 씨앗 증대 및 규제 데이터 수집을 위해 오하이오, 미주리, 아이오와에서 진행되고 있습니다. Moolec는 Piggy Sooy™ 재배를 위한 USDA-APHIS 승인을 최근에 받았으며, 이는 분자 농업에서 중요한 이정표가 됩니다. 이 회사는 농업과 생명공학에서 지속 가능한 솔루션을 제공하는 것을 목표로 하며, Piggy Sooy™는 에이커당 10마리의 돼지에 해당하는 돼지고기 단백질을 생산하면서 환경 영향을 줄일 가능성이 있습니다.
Moolec Science SA (NASDAQ:MLEC) a annoncé la prochaine récolte de ses produits cultivés à partir de plantes génétiquement modifiées GLASO™ et Piggy Sooy™ en octobre 2024. La campagne GLASO™ dans l'Idaho couvre 600 acres et devrait produire entre 300 et 400 tonnes de graines de carthame à haute teneur en GLA. Moolec a sécurisé un contrat de prise en charge avec une grande entreprise mondiale de biens de consommation emballés pour le GLASO™, visant le marché américain en 2025. Des essais sur le terrain de Piggy Sooy™ sont en cours dans l'Ohio, le Missouri et l'Iowa pour le développement du produit, l'augmentation des semences et la collecte de données réglementaires. Moolec a récemment obtenu l'approbation du USDA-APHIS pour la culture de Piggy Sooy™, marquant une étape importante dans l'agriculture moléculaire. L'entreprise vise à fournir des solutions durables en agriculture et en biotechnologie, avec Piggy Sooy™ pouvant potentiellement produire des protéines de viande porcine équivalentes à 10 porcs par acre tout en diminuant l'impact environnemental.
Moolec Science SA (NASDAQ:MLEC) hat die bevorstehende Ernte seiner gentechnisch veränderten Pflanzenprodukte GLASO™ und Piggy Sooy™ im Oktober 2024 angekündigt. Die GLASO™ Kampagne in Idaho umfasst 600 Acres und wird voraussichtlich 300-400 Tonnen Hoch-GLA Saflor-Samen erbringen. Moolec hat eine Abnahmevereinbarung mit einem großen globalen CPG-Unternehmen für GLASO™ gesichert, mit Blick auf den US-Markt im Jahr 2025. Feldversuche mit Piggy Sooy™ werden in Ohio, Missouri und Iowa durchgeführt, um Produkte zu entwickeln, die Samenproduktion zu steigern und regulatorische Daten zu sammeln. Moolec hat kürzlich die Genehmigung des USDA-APHIS für den Anbau von Piggy Sooy™ erhalten, was einen bedeutenden Meilenstein in der molekularen Landwirtschaft darstellt. Das Unternehmen zielt darauf ab, nachhaltige Lösungen in der Landwirtschaft und Biotechnologie anzubieten, wobei Piggy Sooy™ möglicherweise Schweinefleischproteine produzieren kann, die 10 Schweinen pro Acre entsprechen, während gleichzeitig die Umweltauswirkungen reduziert werden.
- Secured offtake agreement with major global CPG company for GLASO™ product
- GLASO™ contains 3 times more GLA than conventional sources
- Obtained USDA-APHIS approval for Piggy Sooy™ cultivation in the US
- Piggy Sooy™ potentially produces pork meat proteins equivalent to 10 pigs per acre
- Expanding commercial strategy to reach larger markets and clients
- None.
Insights
This harvest announcement for GLASO™ and Piggy Sooy™ marks a significant milestone in Molecular Farming. The 600-acre GLASO™ campaign demonstrates Moolec's ability to scale up production, with an expected yield of 300-400 tons of GLA-rich safflower seeds. This output, coupled with the secured offtake agreement, positions Moolec strongly in the GLA market.
The Piggy Sooy™ field trials across three states are important for regulatory approval and product development. The USDA-APHIS approval for cultivation is a groundbreaking achievement, potentially revolutionizing protein production. The claim that one acre could produce proteins equivalent to 10 pigs is impressive, but requires further validation.
Overall, these developments showcase Moolec's progress in translating biotech innovations into commercial products, potentially disrupting traditional agriculture and food industries.
Moolec's progress with GLASO™ and Piggy Sooy™ could significantly impact the food ingredients market. The offtake agreement with a major global CPG company for GLASO™ validates market demand and provides a clear path to commercialization. With
Piggy Sooy™'s potential to produce pork proteins more sustainably aligns with the growing trend of alternative proteins, projected to reach
Moolec's Molecular Farming approach presents a promising solution for sustainable protein production. The claim that Piggy Sooy™ could produce pork proteins equivalent to 10 pigs per acre with reduced environmental impact is significant. Traditional pork production typically requires 2-5 acres per pig, suggesting a potential 20-50x increase in land efficiency.
Moreover, conventional pork production accounts for
LUXEMBOURG / ACCESSWIRE / September 5, 2024 / Moolec Science SA (NASDAQ:MLEC) ("The Company", "Moolec"), a science-based food ingredient company, announced today the harvest confirmation of US campaigns for genetically engineered plant-grown products GLASO™ and Piggy Sooy™ during October 2024.
GLASO™ (gamma-linolenic acid -GLA- in safflower oil) campaign located in Idaho consists of 600 planted acres of genetically modified safflower, mainly for commercial purposes. As a result of the harvest, Moolec is expecting to produce between 300 to 400 tons of safflower seeds that contain high levels of GLA. To allocate most of the upcoming GLASO™ production, Moolec has secured an offtake agreement with a major global CPG company, targeting the US market in 2025. Following a successful and rigorous audit from Moolec's CPG customer, production is set to begin in late 2024.
The Company is also developing a broader commercial strategy to reach larger markets and clients. Moolec's GLASO™ product contains almost 3 times more GLA than conventional sources such as borage and primrose oil, making it the most concentrated GLA oil available on the market.
Piggy Sooy™ (porcine myoglobin in soybean seeds) field trials are being carried out in 3 different US locations: Ohio, Missouri and Iowa. Main purposes for the campaign are product development (sampling), seed increase and gathering of environmental and regulatory data to continue Moolec's US-FDA approval pathway. The Team also projects a remarkable first open field performance for its bioengineered soybean Piggy Sooy™ after recent approval for cultivation from USDA-APHIS. This has set an unprecedented milestone in biotechnology last April, with Moolec becoming the first Molecular Farming company to obtain this kind of clearance for food crops growing animal proteins in US territory.
Chief Technology Officer and Co-Founder Martín Salinas stated: "Our commitment to scaling Moolec's Molecular Farming Technology is demonstrated by our GLASO™ campaign and the field trials of Piggy Sooy™. These efforts not only reinforce our position as pioneers in the industry but also lay the foundation for sustainable solutions in agriculture and biotechnology." He then finished by remarking: "One acre of Piggy Sooy™ could potentially produce pork meat proteins equivalent to 10 pigs, reducing water footprint, land usage and CO2 emissions. This is a clear demonstration on how we promote environmental improvements throughout all our operations. Our aim is to heal the meat production system."
Contact Information
Press & Media
comms@moolecscience.com
Investor Relations
ir@moolecscience.com
Related Files
SOURCE: Moolec Science
View the original press release on newswire.com.
FAQ
When will Moolec Science (MLEC) harvest its GLASO™ and Piggy Sooy™ products in the US?
How many acres of GLASO™ safflower has Moolec Science (MLEC) planted in Idaho?
What is the expected yield of GLASO™ safflower seeds for Moolec Science (MLEC)?
In which US states is Moolec Science (MLEC) conducting Piggy Sooy™ field trials?
What significant approval did Moolec Science (MLEC) receive for Piggy Sooy™ cultivation?
